NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the presence of t(9;22) chromosomal translocation that results in BCR-ABL fusion gene. ABL tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, and dasatinib, are currently the front-line treatment options for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ming-Chin, Cheng, Hung-I, Hsu, Kate, Hsu, Yen-Ning, Kao, Chen-Wei, Chang, Yi-Fang, Lim, Ken-Hong, Chen, Caleb Gonshen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344416/
https://www.ncbi.nlm.nih.gov/pubmed/30705677
http://dx.doi.org/10.3389/fimmu.2018.03152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344416/
https://www.ncbi.nlm.nih.gov/pubmed/30705677
http://dx.doi.org/10.3389/fimmu.2018.03152

Ejemplares similares